A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells
A family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/7/1592 |
id |
doaj-13705ff2ed634604983942486faea1e0 |
---|---|
record_format |
Article |
spelling |
doaj-13705ff2ed634604983942486faea1e02020-11-25T02:05:23ZengMDPI AGMolecules1420-30492020-03-01251592159210.3390/molecules25071592A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer CellsAdhan Pilon0Ana Rita Brás1Leonor Côrte-Real2Fernando Avecilla3Paulo J. Costa4Ana Preto5M. Helena Garcia6Andreia Valente7Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalGrupo Xenomar, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Química, Facultade de Ciencias, Universidade da Coruña, Campus de A Coruña, 15071 A Coruña, SpainFaculty of Sciences, University of Lisboa, BioISI—Biosystems & Integrative Sciences Institute, Campo Grande, C8 bdg, 1749-016 Lisboa, PortugalCentre of Molecular and Environmental Biology, Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalCentro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, PortugalA family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>); 4-hydroxymethylbenzonitrile (<b>3</b>); 4-aminobenzonitrile (<b>4</b>); 4-bromobenzonitrile (<b>5</b>); and, 4-chlorocinnamonitrile (<b>6</b>)). All of the compounds were obtained in good yields and were completely characterized by standard spectroscopic and analytical techniques. Compounds <b>1</b>, <b>4</b>, and <b>5</b> crystallize in the monoclinc P21/c space group and packing is determined by short contacts between the phosphane phenyl rings and cyclopentadienyl (compounds <b>1</b> and <b>4</b>) or π-π lateral interactions between the benzonitrile molecules (complex <b>5</b>). DFT and TD-DFT calculations were performed to help in the interpretation of the experimental UV-Vis. data and assign the electronic transitions. Cytotoxicity studies in MDA-MB-231 breast and SW480 colorectal cancer-derived cell lines showed IC<sub>50</sub> values at a low micromolar range for all of the compounds in both cell lines. The determination of the selectivity index for colorectal cells (SW480 vs. NCM460, a normal colon-derived cell line) indicates that the compounds have some inherent selectivity. Further studies on the SW480 cell line demonstrated that the compounds induce cell death by apoptosis, inhibit proliferation by inhibiting the formation of colonies, and affect the actin-cytoskeleton of the cells. These results are not observed for the hydroxylated compounds <b>2</b> and <b>3</b>, where an alternative mode of action might be present. Overall, the results indicate that the substituent at the nitrile-based ligand is associated to the biological activity of the compounds.https://www.mdpi.com/1420-3049/25/7/1592iron(II)-cyclopentadienylnitrile-based ligandscolorectal cancertriple negative breast cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adhan Pilon Ana Rita Brás Leonor Côrte-Real Fernando Avecilla Paulo J. Costa Ana Preto M. Helena Garcia Andreia Valente |
spellingShingle |
Adhan Pilon Ana Rita Brás Leonor Côrte-Real Fernando Avecilla Paulo J. Costa Ana Preto M. Helena Garcia Andreia Valente A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells Molecules iron(II)-cyclopentadienyl nitrile-based ligands colorectal cancer triple negative breast cancer |
author_facet |
Adhan Pilon Ana Rita Brás Leonor Côrte-Real Fernando Avecilla Paulo J. Costa Ana Preto M. Helena Garcia Andreia Valente |
author_sort |
Adhan Pilon |
title |
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells |
title_short |
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells |
title_full |
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells |
title_fullStr |
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells |
title_full_unstemmed |
A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells |
title_sort |
new family of iron(ii)-cyclopentadienyl compounds shows strong activity against colorectal and triple negative breast cancer cells |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2020-03-01 |
description |
A family of compounds with the general formula [Fe(η<sup>5</sup>-C<sub>5</sub>H<sub>5</sub>)(CO)(PPh<sub>3</sub>)(NCR)]<sup>+</sup> has been synthesized (NCR = benzonitrile (<b>1</b>); 4-hydroxybenzonitrile (<b>2</b>); 4-hydroxymethylbenzonitrile (<b>3</b>); 4-aminobenzonitrile (<b>4</b>); 4-bromobenzonitrile (<b>5</b>); and, 4-chlorocinnamonitrile (<b>6</b>)). All of the compounds were obtained in good yields and were completely characterized by standard spectroscopic and analytical techniques. Compounds <b>1</b>, <b>4</b>, and <b>5</b> crystallize in the monoclinc P21/c space group and packing is determined by short contacts between the phosphane phenyl rings and cyclopentadienyl (compounds <b>1</b> and <b>4</b>) or π-π lateral interactions between the benzonitrile molecules (complex <b>5</b>). DFT and TD-DFT calculations were performed to help in the interpretation of the experimental UV-Vis. data and assign the electronic transitions. Cytotoxicity studies in MDA-MB-231 breast and SW480 colorectal cancer-derived cell lines showed IC<sub>50</sub> values at a low micromolar range for all of the compounds in both cell lines. The determination of the selectivity index for colorectal cells (SW480 vs. NCM460, a normal colon-derived cell line) indicates that the compounds have some inherent selectivity. Further studies on the SW480 cell line demonstrated that the compounds induce cell death by apoptosis, inhibit proliferation by inhibiting the formation of colonies, and affect the actin-cytoskeleton of the cells. These results are not observed for the hydroxylated compounds <b>2</b> and <b>3</b>, where an alternative mode of action might be present. Overall, the results indicate that the substituent at the nitrile-based ligand is associated to the biological activity of the compounds. |
topic |
iron(II)-cyclopentadienyl nitrile-based ligands colorectal cancer triple negative breast cancer |
url |
https://www.mdpi.com/1420-3049/25/7/1592 |
work_keys_str_mv |
AT adhanpilon anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT anaritabras anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT leonorcortereal anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT fernandoavecilla anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT paulojcosta anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT anapreto anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT mhelenagarcia anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT andreiavalente anewfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT adhanpilon newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT anaritabras newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT leonorcortereal newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT fernandoavecilla newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT paulojcosta newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT anapreto newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT mhelenagarcia newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells AT andreiavalente newfamilyofironiicyclopentadienylcompoundsshowsstrongactivityagainstcolorectalandtriplenegativebreastcancercells |
_version_ |
1724938302977474560 |